AU Patent

AU2015203688B2 — Diketopiperazine microparticles with defined specific surface areas

Assigned to Mannkind Corp · Expires 2016-04-07 · 10y expired

What this patent protects

[00108] Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.

USPTO Abstract

[00108] Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015203688B2
Jurisdiction
AU
Classification
—
Expires
2016-04-07
Drug substance claim
No
Drug product claim
No
Assignee
Mannkind Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.